MAO LI enters LEGEND BIOTECH CORP with 44.33K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0002106809-26-000002
44.33K
Baseline shares
100% direct
44.33K
Direct ownership
1 position
30K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned44.33K
Total
44.33K direct44.33K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 44.33K | Direct |
| Total | 44.33K | 44.33K direct |
Derivative Holdings1
Share Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
30K
Shares owned
N/A
Exercise price
23.27
Expiration
—
Exercise window
—
Total
Underlying
30K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares | 23.27 | — | — | 30K | N/A |
| Total | 30K | 0.00 | ||||